Th17 lymphocytes protect mucosal barriers from infections, but also
contribute to multiple chronic inflammatory diseases. Their differentiation is
controlled by RORγt, a ligand-regulated nuclear receptor. We identified
the DEAD-box RNA helicase DDX5 as a RORγt partner that coordinates
transcription of selective Th17 genes and is required for Th17-mediated
inflammatory pathologies. Surprisingly, the ability of DDX5 to interact with
RORγt and co-activate its targets depends on its intrinsic RNA helicase
activity and binding of a conserved nuclear long noncoding RNA (lncRNA), Rmrp,
which is mutated in Cartilage-Hair Hypoplasia (CHH) patients. A targeted
Rmrp mutation in mice, corresponding to one in CHH
patients, abrogated the lncRNA’s chromatin recruitment, ability to
potentiate DDX5-RORγt interaction and RORγt target gene
transcription. Elucidation of the link between Rmrp and the DDX5-RORγt
complex reveals a role for RNA helicases and lncRNAs in tissue-specific
transcriptional regulation and promises new opportunities for therapeutic
intervention in Th17-dependent diseases.
Kingella kingae is an emerging pediatric pathogen and is increasingly recognized as a leading etiology of septic arthritis, osteomyelitis, and bacteremia and an occasional cause of endocarditis in young children. The pathogenesis of K. kingae disease begins with colonization of the upper respiratory tract followed by breach of the respiratory epithelial barrier and hematogenous spread to distant sites of infection, primarily the joints, bones, and endocardium. As recognition of K. kingae as a pathogen has increased, interest in defining the molecular determinants of K. kingae pathogenicity has grown. This effort has identified numerous bacterial surface factors that likely play key roles in the pathogenic process of K. kingae disease, including type IV pili and the Knh trimeric autotransporter (adherence to the host), a potent RTX-family toxin (epithelial barrier breach), and multiple surface polysaccharides (complement and neutrophil resistance). Herein, we review the current state of knowledge of each of these factors, providing insights into potential approaches to the prevention and/or treatment of K. kingae disease.
Kingella kingae
is an emerging pediatric pathogen and produces invasive disease by colonizing the oropharynx, invading the bloodstream, and disseminating to distant sites. This organism produces a uniquely multifunctional exopolysaccharide called galactan that is critical for virulence and promotes intravascular survival by mediating resistance to serum and neutrophils.
Change History: This Article has been retracted; see accompanying Retraction. Corrected online 20 January: In this Article, author Frank Rigo was incorrectly listed with a middle initial; this has been corrected in the online versions of the paper.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.